Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 8,821 - 8,840 results of 64,663 for search '(( 5 a decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (nn decrease)) ))', query time: 1.08s Refine Results
  1. 8821
    Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx

    Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  2. 8822
    Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg

    Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  3. 8823
    Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg

    Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  4. 8824
    Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx

    Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  5. 8825
    Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg

    Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  6. 8826
    Occupational risk factors for asthma exacerbation in adults: a five-year follow-up of the Norwegian Telemark study cohort

    Occupational risk factors for asthma exacerbation in adults: a five-year follow-up of the Norwegian Telemark study cohort by N Zivadinovic (21239948)

    Published 2025
    “…</p> <p><b><i>Methods:</i></b> In a prospective study of respiratory health in Telemark, Norway, 1857 adult participants with physician-diagnosed asthma were invited to participate in a follow-up survey. …”
    Save to List
    Saved in:
  7. 8827
    Image_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg

    Image_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
    Save to List
    Saved in:
  8. 8828
    Table_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx

    Table_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…</p>Methods<p>522 PwMS and 68 healthy controls vaccinated with BNT162b2-Pfizer mRNA vaccine against SARS-CoV-2, or recovering from COVID-19, were recruited in a nation-wide multi-center study. …”
    Save to List
    Saved in:
  9. 8829
    Table_2_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx

    Table_2_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…</p>Methods<p>522 PwMS and 68 healthy controls vaccinated with BNT162b2-Pfizer mRNA vaccine against SARS-CoV-2, or recovering from COVID-19, were recruited in a nation-wide multi-center study. …”
    Save to List
    Saved in:
  10. 8830
    Table_3_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx

    Table_3_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…</p>Methods<p>522 PwMS and 68 healthy controls vaccinated with BNT162b2-Pfizer mRNA vaccine against SARS-CoV-2, or recovering from COVID-19, were recruited in a nation-wide multi-center study. …”
    Save to List
    Saved in:
  11. 8831
    Image_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.tif

    Image_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.tif by Ron Milo (22493)

    Published 2022
    “…</p>Methods<p>522 PwMS and 68 healthy controls vaccinated with BNT162b2-Pfizer mRNA vaccine against SARS-CoV-2, or recovering from COVID-19, were recruited in a nation-wide multi-center study. …”
    Save to List
    Saved in:
  12. 8832
    Summarizes differential abundance of commensals and opportunistic microbes modulating disease trajectory in vaccination breakthroughs and unvaccinated infections of SARS-CoV-2.

    Summarizes differential abundance of commensals and opportunistic microbes modulating disease trajectory in vaccination breakthroughs and unvaccinated infections of SARS-CoV-2. by Priti Devi (10888155)

    Published 2023
    Save to List
    Saved in:
  13. 8833
    The expression level of hub genes in EOC tissues at different stages.

    The expression level of hub genes in EOC tissues at different stages. by Ting Gui (304563)

    Published 2021
    “…According to the result, there were significant variations in the expression levels of CDC45, CDCA5, KIF4A, and ESPL1 (a-d). The overall trends indicated that the expression of these four genes decreased gradually with the continuous progression of OC.…”
    Save to List
    Saved in:
  14. 8834
    One-carbon metabolism perturbations in liver of <i>Fmo5</i><sup><i>-/-</i></sup> mice.

    One-carbon metabolism perturbations in liver of <i>Fmo5</i><sup><i>-/-</i></sup> mice. by Ian R. Phillips (5074121)

    Published 2023
    “…<p>Red indicates an increase, blue a decrease and black no change in metabolite abundance or gene expression in <i>Fmo5</i><sup><i>-/-</i></sup> vs WT mouse liver. …”
    Save to List
    Saved in:
  15. 8835
    RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression.

    RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

    Published 2024
    Save to List
    Saved in:
  16. 8836
    Differences in abundance in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice of products of microbial and host-conjugation reactions.

    Differences in abundance in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice of products of microbial and host-conjugation reactions. by Ian R. Phillips (5074121)

    Published 2023
    Save to List
    Saved in:
  17. 8837
    Longitudinal phenotypic study of late-onset retinal degeneration due to a founder variant c.562C>A p.(Pro188Thr) in the <i>C1QTNF5</i> gene

    Longitudinal phenotypic study of late-onset retinal degeneration due to a founder variant c.562C>A p.(Pro188Thr) in the <i>C1QTNF5</i> gene by Julie De Zaeytijd (3633118)

    Published 2021
    “…<p><b>Background</b>: Late-onset retinal degeneration (L-ORD) is a rare autosomal dominant retinal dystrophy related to <i>C1QTNF5</i> gene variants.…”
    Save to List
    Saved in:
  18. 8838
    Characterization of the cyclin-deficient virus expressing a LANA β-lactamase gene fusion.

    Characterization of the cyclin-deficient virus expressing a LANA β-lactamase gene fusion. by Brian F. Niemeyer (11707995)

    Published 2021
    Save to List
    Saved in:
  19. 8839
    Loss of RBM-26 causes mitochondria dysfunction in PLM.

    Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

    Published 2024
    Save to List
    Saved in:
  20. 8840
    Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects.

    Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

    Published 2024
    Save to List
    Saved in:

Search Tools: